QA102 Phase II Study in Subjects With Dry AMD

NCT05536752 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Age-related Macular Degeneration

Interventions

DRUG: QA102/Placebo
DRUG: QA102
DRUG: Placebo

Sponsor

Smilebiotek Zhuhai Limited